Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder: a Randomized Placebo-controlled Trial BLUME (Blue Light Filtering in Manic Episodes)

NCT06748716 is registered in ClinicalTrials.gov with Rayan NASSERDINE as lead sponsor.

NCT NCT06748716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06748716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder: a Randomized Placebo-controlled Trial BLUME (Blue Light Filtering in Manic Episodes)
Lead sponsor
Rayan NASSERDINE
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 1, 2025
Completion date
April 1, 2028
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actigraphy, bipolar, bipolar disorder (bd), dark therapy, mania, manic, rct, virtual darkness